Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vaginal mucins are high-molecular-weight glycoproteins, primarily MUC1, MUC4, MUC5B, and MUC16, that form the structural framework of the cervicovaginal mucus (CVM) (PubMed: 15707447). These proteins are characterized by extensive O-glycosylation, which allows them to retain water and provide essential lubrication and barrier functions against pathogens and mechanical friction (NCBI: NBK542186). In therapeutic applications, these glycoproteins act as the primary docking site for mucoadhesive polymers such as polycarbophil. Polycarbophil, a high-molecular-weight polymer of acrylic acid, interacts with the mucin layer through hydrogen bonding between its carboxylic acid groups and the sugar residues of the mucins, as well as through physical chain entanglement (PubChem: CID 6850774). This interaction facilitates the prolonged residence time of drugs, such as progesterone or dinoprostone, and helps maintain vaginal hydration in conditions like atrophic vaginitis (StatPearls: NBK559283). By adhering to the mucus layer, these polymers provide a sustained release platform for local treatments while simultaneously acting as a humectant to alleviate symptoms of dryness.
Mucoadhesion through hydrogen bonding and physical chain entanglement between polymer chains (e.g., polycarbophil) and the oligosaccharide side chains of mucin glycoproteins.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal mucin (MUC).